Chemoinformaics analysis of 1,1-Diphenylpropane
| Molecular Weight | 196.293 | nRot | 3 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 12 |
| Exact Molecular Weight | 196.125 | nRing | 2 |
| Solubility: LogS | -5.068 | nHRing | 0 |
| Solubility: LogP | 4.961 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 2 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 12 |
| nHA | 0 | APOL | 35.7187 |
| nHD | 0 | BPOL | 16.0513 |
| QED | 0.689 |
| Synth | 1.464 |
| Natural Product Likeliness | -0.196 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.131 |
| Pgp-sub | 0.766 |
| HIA | 0.002 |
| CACO-2 | -4.502 |
| MDCK | 0.0000158 |
| BBB | 0.849 |
| PPB | 0.965852 |
| VDSS | 1.301 |
| FU | 0.0212083 |
| CYP1A2-inh | 0.711 |
| CYP1A2-sub | 0.897 |
| CYP2c19-inh | 0.814 |
| CYP2c19-sub | 0.664 |
| CYP2c9-inh | 0.696 |
| CYP2c9-sub | 0.086 |
| CYP2d6-inh | 0.897 |
| CYP2d6-sub | 0.105 |
| CYP3a4-inh | 0.054 |
| CYP3a4-sub | 0.626 |
| CL | 5.312 |
| T12 | 0.104 |
| hERG | 0.044 |
| Ames | 0.046 |
| ROA | 0.167 |
| SkinSen | 0.154 |
| Carcinogencity | 0.587 |
| EI | 0.832 |
| Respiratory | 0.049 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.602146 |